JPRN-UMIN000004097已完成未知
Prospective combined analysis of spirometry, impulse oscillation, and chest tomography for the effect of salmeterol/fluticasone (SFC) in COPD - Prospective analysis of spirometry and chest tomography for the effect of salmeterol/fluticazone (SFC) in COPD
agoya University Graduate School of Medicine0 个研究点目标入组 34 人开始时间: 2010年8月25日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 34
研究概览
简要总结
The clinical trial was discontinued due to small numbers.
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. any disease with possible air flow limitation defined as below 2.defined as below; bronchial asthma, diffuse pan bronchitis, sinobronchial syndrome, bronchial ectasis, tuberculosis, pneumoconiosis, lymphangioleiomyomatosis, congestic heart failure, and interstitial pneumonia detected by chest Xray 3. contraindication to SFC treatment
研究者
相似试验
已完成
2 期
Efficacy and safety of weekly nab-paclitaxel plus CBDCA in patients with CUPcancer of unknown primaryCUP, nab-Paclitaxel,CBDCAJPRN-jRCTs051180084Yagi Toshinari17
已完成
不适用
Randomized trial of telmisartan and/or enalapril on renoprotective effects for patients of chronic renal diseases with hypertension.Chronic Kidney DiseasesJPRN-C000000299Institute of Clinical Medicine, University of Tsukuba150
已完成
1 期
Combination therapy with immune-cell therapy and immune check point inhibitor.malignant tumorJPRN-jRCTc031210185Takimoto Rishu3
已完成
2 期
Combination therapy with immune-cell therapy and immune check point inhibitormalignant tumorJPRN-jRCTc031190100Takimoto Rishu40
已完成
2 期
Combination therapy with immune-cell therapy and immune check point inhibitormalignant tumorJPRN-jRCTc031190098Takimoto Rishu40